Metabolomics Workbench : NIH Data Repository

MB Sample ID: SA242812

Local Sample ID:	C21
Subject ID:	SU002517
Subject Type:	Human
Subject Species:	Homo sapiens
Taxonomy ID:	9606
Age Or Age Range:	18-65
Gender:	Male and female
Human Exclusion Criteria:	HIV patients, respiratory infections beside TB, diabetes, chronic renal failure history and transplanted. individuals

Select appropriate tab below to view additional metadata details:

All
Subject
Factors
Collection
Treatment
Sample Preparation
Chromatography
Analysis
MS

Treatment:

Treatment ID:	TR002529
Treatment Summary:	Blood was allowed to clot for three hours at 4°C after collection. The blood was then centrifuged at 1000 xg at 4°C for 30 min. Serum collected after centrifugation was passed through 0.2 μm filters (Sterile Acrodisc®, syringe filters with Supor membrane, 32 mm) to remove bacteria. Finally, an anti-protease cocktail (Protease Inhibitor Cocktail, ©SIGMA) was added to the filtered serum. The samples were transported from INSA to ITQB in a liquid nitrogen container and stored at −80°C.

Treatment ID:

TR002529

Treatment Summary:

Blood was allowed to clot for three hours at 4°C after collection. The blood was then centrifuged at 1000 xg at 4°C for 30 min. Serum collected after centrifugation was passed through 0.2 μm filters (Sterile Acrodisc®, syringe filters with Supor membrane, 32 mm) to remove bacteria. Finally, an anti-protease cocktail (Protease Inhibitor Cocktail, ©SIGMA) was added to the filtered serum. The samples were transported from INSA to ITQB in a liquid nitrogen container and stored at −80°C.